Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Assessing the pros and cons of zero based budgeting can guide your financial planning. Discover what works best for your situation.
28,655 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
The BEA final read confirms economy grew 2.1% first quarter, signaling momentum. Here’s what drove growth and what ho...
JPMorgan Chase stock slumped today by nearly 2%, a move that caught traders’ attention. This article breaks down the ...
A major fund plowed into a top U.S. homebuilder with a $65 million stake, ahead of a rumored $47-per-share buyout. He...
When a CEO sells stock, it invites questions. This guide breaks down Zoom's sold company stock, what it signals about...
What the arcturus (arct) 2025 earnings report may reveal isn’t just about a single quarter. This guide breaks down th...
Curious how your tax refund compares to the typical 2026 outcome? This guide breaks down what drives refunds, how to ...
As earnings season hits, the focus is on Taiwan Semiconductor. This original analysis breaks down why prediction: Tai...
UWM introduces a temporary pricing incentive for eligible refinances and purchases, while Chase launches a short-term...
When a major holding shows a sharp fall after earnings, investors scramble for answers. This guide breaks down the re...
Jupiter, the Solana-based decentralized exchange, expands into tokenized IP by listing onchain Pokémon cards. The mov...
February brought a sharp pullback for Robinhood, driven by crypto swings and a broader shift in its business model. T...